Home » EUROFINS STRENGTHENS POSITION IN GLOBAL CLINICAL TRIALS MARKET WITH ACQUISITION OF FOCUS BIO-INOVA
EUROFINS STRENGTHENS POSITION IN GLOBAL CLINICAL TRIALS MARKET WITH ACQUISITION OF FOCUS BIO-INOVA
Eurofins Scientific strengthens its position in the global clinical trials market, and expands its testing services portfolio to the pharmaceutical and biotechnology industries with the acquisition of Focus Bio-Inova (FBI).
Euronext
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May